FDANonrulemakingFDA-2025-D-3049

Who commented on this docket

Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 216d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 216d ago

Abstract

OPEN

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.

Who Commented on Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products; Draft Guidance for Industry; Availability (FDA-2025-D-3049) | OpenPolis